Announcements Trials

Browse Landscape

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 38 Breast Neoplasms 31 Lung Neoplasms 25 Colorectal Neoplasms 15 Prostatic Neoplasms 13 Pancreatic Neoplasms 11 Ovarian Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Head and Neck Neoplasms 9 Sarcoma 8 Colonic Neoplasms 8 Carcinoma, Hepatocellular 8 Uterine Cervical Neoplasms 7 Glioma 7 Esophageal Neoplasms 7 Melanoma 6 Lymphoma 6 Endometrial Neoplasms 6 Neoplastic Cells, Circulating 5 Multiple Myeloma 5 Brain Neoplasms 5 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm, Residual 4 Gastrointestinal Neoplasms 4 Carcinoma, Squamous Cell 4 Carcinoma, Renal Cell 4 Adenocarcinoma 4 Thrombosis 3 Rectal Neoplasms 3

Interventions

abemaciclib 3 ribociclib 2 palbociclib 2 exemestane 2 Tamoxifen 2 Fulvestrant 2 Anastrozole 2 sacubitril and valsartan sodium hydrate drug combination 1 elacestrant 1 dalpiciclib 1 STX-478 1 RAD1901 1 Metformin 1 Letrozole 1 Imlunestrant 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Breast Diseases × Blood Specimen Collection × Clear all

NCT07010939 2025-09-12

PERSEVERE

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡